Astorg, Goldman Sachs to sell HRA Pharma for EUR 1.8bn

  • by

Perrigo Company, a listed Irish healthcare and pharmaceutical company, has signed a binding offer to acquire HRA Pharma, a French consumer self-care company, from Astorg and Goldman Sachs Asset Management for EUR 1.8bn in cash.

Source link

Leave a Reply

Your email address will not be published.